Stimulation of MC38 tumor growth by insulin analog X10 involves the serine synthesis pathway

Henning Hvid(Jewish General Hospital), Michaël Pollak(Jewish General Hospital)

Endocrine Related Cancer

June 8, 2012

10.1530/erc-12-0125

Cited by 10

Related Papers

Metformin Is an AMP Kinase–Dependent Growth Inhibitor for Breast Cancer Cells

|Cancer Research|2006|1k

Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth

|Endocrine Related Cancer|2008|184

Inhibition of insulin-like growth factor-1 receptor signaling enhances growth-inhibitory and proapoptotic effects of gefitinib (Iressa) in human breast cancer cells

|Breast Cancer Research|2005|121

Alterations in Cellular Energy Metabolism Associated with the Antiproliferative Effects of the ATM Inhibitor KU-55933 and with Metformin

|PLoS ONE|2012|37